A Potential Next Generation Sclerostin Inhibitor Specifically Targets Sclerostin Monomer for Bone Anabolic Therapy with Low Cardiovascular Risk to Reverse Established Osteoporosis in Ovariectomized Rats (Abstract)

Yuanyuan Yu, Qing Ren, Shuaijian Ni, Jin Liu, Chuanxin Zhong, Jun Lu, Yuan Tang, Dijie Li, Duoli Xie, Rongchen Dai, Huarui Zhang, Lei Dang, Aiping Lyu, Ge Zhang, Zhenjian Zhuo, Zong-Kang Zhang, Bao Ting Zhang, Luyao Wang, Yongshu Li, Kui Kwan WongJoseph Zhai

Research output: Contribution to journalConference articlepeer-review

Original languageEnglish
Pages (from-to)264
Number of pages1
JournalJournal of Bone and Mineral Research
Issue numberS1
Publication statusPublished - Dec 2019
Event2019 Annual Meeting of the American Society for Bone and Mineral Research, ASBMR 2019 - Orange County Convention Center, Orlando, United States
Duration: 20 Sept 201923 Sept 2019
https://onlinelibrary.wiley.com/doi/abs/10.1002/jbmr.3936 (Conference abstract)

Cite this